Rewind Therapeutics is developing first-in-class remyelinating therapies for myelin-related diseases and aims to bring them into fast-track clinical development.
Myelin-related diseases, such as multiple sclerosis, are those where the myelin sheath surrounding nerves is damaged leading to deficient nerve transmission that may affect multiple functions, including sensation, cognition and movement, among others. The causes of damage may be genetic, a result of infectious or autoimmune disease or from exposure to toxic agents or other forms of brain injury. There is no cure for demyelinating diseases.
The Company was founded by KU Leuven’s Centre for Drug Design and Discovery (CD3) and Axxam S.p.A. (Milano, Italy), a leading provider of integrated discovery services for the Life Sciences. Rewind Therapeutics works in close collaboration with both organisations and a world-class academic network to advance its discovery and development activities.
Rewind Therapeutics is backed by life science investors Boehringer Ingelheim Venture Fund, M Ventures and the Flemish investment company PMV, together with CD3 and KU Leuven Gemma Frisius Fonds.
Company Details
- Employees
- 19
- Founded
- -
- Address
- Gaston Geenslaan, Heverlee,flemish Region 3001,belgium
- in****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- rewindtherapeutics.com
- Keywords
- biotech, myelin, therapy, multiple sclerosis.
- HQ
- Heverlee, Flemish Region
Rewind Therapeutics Questions
Rewind Therapeutics's website is rewindtherapeutics.com
Rewind Therapeutics's LinkedIn profile is https://be.linkedin.com/company/rewind-therapeutics
Rewind Therapeutics has
19 employees.
View email and phone details for 19
employees at Rewind Therapeutics.
Rewind Therapeutics's industry is
Biotechnology Research
Rewind Therapeutics's top competitors are
Etherna,
Augustine Therapeutics,
Exevir,
Agomab,
Confo Therapeutics,
Oxurion Nv,
Flamingo Therapeutics,
Montis Biosciences,
Remynd,
Breye Therapeutics Aps.
Rewind Therapeutics's support email address is information@rewindtherapeutics.com
Rewind Therapeutics's categories are Biotechnology Research
Rewind Therapeutics's founding year is 2017
